Granules India (NSE:GRANULES) Debt-to-Equity : 0.41 (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Granules India Debt-to-Equity?

Granules India's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹11,629 Mil. Granules India's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹1,522 Mil. Granules India's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹32,255 Mil. Granules India's debt to equity for the quarter that ended in Mar. 2024 was 0.41.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Granules India's Debt-to-Equity or its related term are showing as below:

NSE:GRANULES' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.39 Med: 0.57 Max: 1.33
Current: 0.41

During the past 13 years, the highest Debt-to-Equity Ratio of Granules India was 1.33. The lowest was 0.39. And the median was 0.57.

NSE:GRANULES's Debt-to-Equity is ranked worse than
58.68% of 847 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs NSE:GRANULES: 0.41

Granules India Debt-to-Equity Historical Data

The historical data trend for Granules India's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Granules India Debt-to-Equity Chart

Granules India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.48

0.39

0.43

0.40

0.41

Granules India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.40	N/A	0.47	N/A	0.41

Competitive Comparison of Granules India's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Granules India's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Granules India's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Granules India's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Granules India's Debt-to-Equity falls into.

Granules India Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Granules India's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11628.95	+	1521.69)	/	32255.44
	=	0.41

Granules India's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11628.95	+	1521.69)	/	32255.44
	=	0.41

Granules India (NSE:GRANULES) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Granules India Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Granules India's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Granules India (NSE:GRANULES) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Granules India Ltd (NSE:GRANULES) » Definitions » Debt-to-Equity

Traded in Other Exchanges

532482:India

Address

3rd Block, My Home Hub, 2nd Floor, Madhapur, Hyderabad, TG, IND, 500 081

Website

https://www.granulesindia.com

Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.

Granules India (NSE:GRANULES) Headlines

No Headlines